Big Rock Partners Acquisition Corp.
Status: Closed Deal
U=S+R+W/2
W=S@11.5
R=S/10
| IPO Proceeds, $M | $69.00M |
|---|---|
| IPO Date | Nov 20, 2017 |
| CEO | Richard Ackerman |
| Left Lead | EarlyBirdCapital |
| IPO Cash in Trust | 100.0% |
| SPAC Tenor | 12+3+3+3+3+4+4+5+4+1 |
| IPO Sector | Healthcare ▶ |
| IPO Geography | US/Canada |
| Target Company | NeuroRx |
| Deal Announced | Dec 14, 2020 |
| Deal Size, $M | $525.07M |
| Deal Sector | Healthcare |
| Deal Geography | US/Canada |
| SEC Filings |
www.sec.gov 
|
| Approval Vote | May 24, 2021 |
| Amendment Vote | TBD |
| Closing Date | May 24, 2021 |
Formerly BRPA
NRXP
NRXPW
| Price | $3.12 $0.31 |
|---|---|
| Last closing price | $3.02 |
| H/L, today | $3.00 / $3.38 |
| H/L, 52-week | $0.22 / $1.53 |
| Volume, today | 1,093,775 |
| Volume, 3-month avg. | N/A |
Sign up for Free Trial
No credit card required
Sign in to view structure, cap table, and calendar of events.